Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=37332Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a biopharmaceutical company developing and manufacturing innovative monoclonal antibodies for the treatment of cancer and serious viral infections. CANCER INFORMATION LINKS: If any of the following links become void or don't work please notify me a...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=3733238013210Terry D.http://www.siliconinvestor.com/readmsg.aspx?msgid=289052355/20/2013 3:47:11 PMTerry D.http://www.siliconinvestor.com/readmsg.aspx?msgid=289011235/17/2013 5:41:41 PMTerry D.4054General Poster Session (Board #17H), Sun, 8:00 AM-11:45 AM Randomized, open-label, phase II trial of gemcitabine with or without bavituximab in patients with nonresectable stage IV pancreatic adenocarcinoma. Shuchi Sumant Pandya, Lucas Wong, Andrea J. Bullock, Stephen A. Grabelsky, Merrill Kingman Shum, Jose...http://www.siliconinvestor.com/readmsg.aspx?msgid=288970435/15/2013 7:34:27 PMTerry D.And these options always get voted in. I find the reasoning behind the 25000 shares as a qualifier for having any vote completely without merit. If you read the posts yesterday you see that the ones who have managed to acquire more than 25000 shares are mostly newer shareholders who got in at lower prices and most of t...http://www.siliconinvestor.com/readmsg.aspx?msgid=288842685/9/2013 10:38:00 AMEACarlWell Terry, just one more indication of the low regard PPHM has for its shareholders. As if we didn't already know....http://www.siliconinvestor.com/readmsg.aspx?msgid=288828335/8/2013 3:19:45 PMDewDiligence_on_SIWhy haven't they gone after Feurstein and Dew Diligence who are much more visible? They both call [Bavituximab] a placebo... Last time I checked, expressing an opinion about a drug candidate on a message board was not a crime. Perhaps that's why PPHM has not taken any action against me, LMAO.http://www.siliconinvestor.com/readmsg.aspx?msgid=288713705/2/2013 3:56:51 PMartpThat's probably what has happened to my inquiries to them as well. I had forgotten about Ricardo. Obviously, PPHM has no sense of humor to pursue it to that extent. Why haven't they gone after Feurstein and Dew Diligence who are much more visible? They both call it a placebo and a sham. How did Feurstein know in ad...http://www.siliconinvestor.com/readmsg.aspx?msgid=288702915/2/2013 8:46:54 AMTerry D.I sent IR an email today asking what research we had a license for besides Thorpe's work. Their reply is as follows. I guess they must have me on the sh!t" list Your message To: Info Subject: Research scientists Sent: Wednesday, May 01, 2013 1:16:22 PM (UTC-08:00) Pacific Time (US & Canada) was deleted w...http://www.siliconinvestor.com/readmsg.aspx?msgid=288697855/1/2013 9:02:09 PMTerry D.Remember Ricardo Lacabeza? Here is the ruling on Peregrine Pharmaceuticals v. Gorman ( Ricardo) case. Interesting reading. I didn't know it went this far. Better be careful of what you post. APPEAL from an order of the Superior Court of San Diego County, Randa Trapp, Judge. Affirmed. Defe...http://www.siliconinvestor.com/readmsg.aspx?msgid=288696155/1/2013 6:42:38 PMTerry D.Has Peregrine become a one trick pony now that Thorpe has passed away? IMO Cotara is a thing of the past. We have a license with Stason which I see going no where and a detriment to any other license deal for Cotara. Do we have any other reseach which we sponsor besides some of Barton's work? Bavi or nothing? Managemen...http://www.siliconinvestor.com/readmsg.aspx?msgid=288683705/1/2013 10:27:10 AMTerry D.TUSTIN, CA--(Marketwired - Apr 29, 2013) - Peregrine Pharmaceuticals (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced the completion of patient enrollment in an investigator-sponsored Phase I trial evaluating b...http://www.siliconinvestor.com/readmsg.aspx?msgid=288644194/29/2013 11:37:29 AMTerry D.http://www.siliconinvestor.com/readmsg.aspx?msgid=288261024/10/2013 11:51:53 AMTerry D.The bar just got higher. Over 3.5 times inprovement over letrozole alone. Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Fo...http://www.siliconinvestor.com/readmsg.aspx?msgid=288259534/10/2013 11:08:41 AMTerry D.Inventor: Thorpe; Philip E. Address: Dallas, TX No. of patents: 55 Patents: [iframe style="left: 0px; top: 0px; position: absolute;" id="aswift_0" height="90" marginHeight="0" frameBorder="0" width="728" allowTransparency="" name="aswift_0" marginWidth="0" scrolling="no"][/iframe] Patent NumberTitle O...http://www.siliconinvestor.com/readmsg.aspx?msgid=288177744/5/2013 11:45:12 AMTerry D. UT Southwestern researchers uncover a genetic vulnerabilityof lung cancer to lay the foundation for new drug options DALLAS – April 4, 2013 – Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells – a specific genetic weakness that can be exploited for ...http://www.siliconinvestor.com/readmsg.aspx?msgid=288159404/4/2013 1:42:04 PMTerry D.http://www.siliconinvestor.com/readmsg.aspx?msgid=288142454/3/2013 4:17:25 PMrjk01http://www.siliconinvestor.com/readmsg.aspx?msgid=288140404/3/2013 3:01:46 PMTerry D.[graphic] Peregrine Pharmaceuticals today mourns the loss of Dr. Philip E. Thorpe, scientific advisor to the company and inventor of our phosphatidylserine (PS)-targeting technology on which our lead drug candidate bavituximab is based. Phil was a Professor of Pharmacology at the University of Texas Southwestern Medi...http://www.siliconinvestor.com/readmsg.aspx?msgid=288127504/2/2013 10:41:16 PMTerry D. From: Campus Updates Sent: Tuesday, April 02, 2013 1:24 PM To: Campus Updates Subject: Passing of Dr. Thorpe To the UT Southwestern Community, It is with deep regret that I write to inform you of the passing of Dr. Philip E. Thorpe, Professor of Pharmacology, who also was associated with the Harol...http://www.siliconinvestor.com/readmsg.aspx?msgid=288125094/2/2013 7:05:46 PMTerry D.United States Patent 8,394,943Kavlie , et al.March 12, 2013 Anti-VEGF antibody compositions and methods Abstract Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two primary VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression...http://www.siliconinvestor.com/readmsg.aspx?msgid=288123334/2/2013 5:11:22 PMTerry D.Don't recall this being posted but it has been a year so it might have been. United States Patent Application20120064001 Kind CodeA1 Kavlie; Anita ; et al.March 15, 2012 Anti-VEGF Antibody Compositions and Methods Abstract Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2...http://www.siliconinvestor.com/readmsg.aspx?msgid=288123084/2/2013 5:01:17 PMTerry D.The Cancer Survival Toolbox® (English)Product DescriptionThe Cancer Survival Toolbox® The Cancer Survival Toolbox is a free, award-winning audio program developed by leading cancer organizations to help people develop important skills to meet the challenges of their illness. You can listen to the program online or orde...http://www.siliconinvestor.com/readmsg.aspx?msgid=288121214/2/2013 3:28:28 PMTerry D.Abstract Number: 4326 Presentation Title: Phosphatidylserine-targeting ‘betabodies’ for the treatment of cancer Presentation Time: Tuesday, Apr 09, 2013, 1:00 PM - 5:00 PM Location: Hall A-C, Poster Section 36 Poster Board Number: 9 Author Block: Xianming Huang1, Dan Ye1, Troy Luster2, E. Sally Ward1, Philip Th...http://www.siliconinvestor.com/readmsg.aspx?msgid=288102954/1/2013 4:14:02 PMTerry D.Abstract Number: 2850 Presentation Title: Predicting anti-tumor responses to phosphatidylserine targeting antibodies using tumor imaging Presentation Time: Tuesday, Apr 09, 2013, 8:00 AM -12:00 PM Location: Hall A-C, Poster Section 21 Poster Board Number: 22 Author Block: Jian Gong1, Richard Archer1, Van Nguyen...http://www.siliconinvestor.com/readmsg.aspx?msgid=288102934/1/2013 4:13:15 PMTerry D.Abstract Number: 1244 Presentation Title:Phosphatidylserine-targeting antibody reactivates tumor immunity and destroys tumor vasculature in mice Presentation Time: Monday, Apr 08, 2013, 1:00 PM - 5:00 PM Location: Hall A-C, Poster Section 5 Poster Board Number: 24 Author Block: Yi Yin, Xianming Huang, Dan Ye, Ph...http://www.siliconinvestor.com/readmsg.aspx?msgid=288102924/1/2013 4:12:33 PMTerry D.Peregrine Announces Three Abstracts Accepted for Presentation at AACR 2013 Annual Meeting TUSTIN, CA--(Marketwire - Apr 1, 2013) - Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announc...http://www.siliconinvestor.com/readmsg.aspx?msgid=288102904/1/2013 4:11:19 PMTerry D.Wouldn't it make sense that if all these people who had signed confidentiality agreements were impressed with the trial results we would be at a higher PPS? We're talking major BP's! Why haven't they taken an active part in Peregrine? According to King quite a few signed these agreements. Wouldn't one of them want to b...http://www.siliconinvestor.com/readmsg.aspx?msgid=287923763/21/2013 8:43:33 PMTerry D.Some newer approved drugs for cancer with link for others approved pre 2012. 3 already approved for 2013. Drugs Approved in 2013 Kadcyla (ado-trastuzumab emtansine); Genentech; For the treatment of HER2-positive metastatic breast cancer, Approved February 2013 Pomalyst (pomalidomide); Celgene; For the treatment of...http://www.siliconinvestor.com/readmsg.aspx?msgid=287859713/18/2013 7:51:37 PMTerry D.Spring isssue 2013 CURE Magazine http://curetoday.com/index.cfm/fuseaction/magazine.show/id/3/magazine_id/59 A wealth of up to date information on treatments and advances in cancer research,http://www.siliconinvestor.com/readmsg.aspx?msgid=287800823/15/2013 11:22:29 AMTerry D.I know some on the other board who could do that but doubt if they would. I guess we can't blame king. The 6 or 7 CEOs who preceded him used the same MO. Next year, next quarter, in partnership talks. New posters praising whatever so called scientific gains we have made, real or imaginary. Posters now more interested i...http://www.siliconinvestor.com/readmsg.aspx?msgid=287779673/14/2013 12:18:30 PMrjk01someone need to cut/paste all those classic lines from last 10y. show you how non creative he is........at least come up with a new hyped pearl of a promises. go Clippers..........http://www.siliconinvestor.com/readmsg.aspx?msgid=287770843/13/2013 8:09:21 PMTerry D.IMO Peregrine is like a runner with one foot nailed to the floor. Always ""we see, we expect, next quarter, 3rd quarter" yet never reaching the goal. King said in his first CC that XXXX was going to be our year and has continued with the same line for his whole time as CEO.http://www.siliconinvestor.com/readmsg.aspx?msgid=287769183/13/2013 6:40:26 PMTerry D. Parasite Immunol. 2013 Mar;35(3-4):109-19. doi: 10.1111/pim.12019. Phosphatidylserine exposure on the surface of Leishmania amazonensis amastigotes modulates in vivo infection and dendritic cell function. Wanderley JL, Thorpe PE, Barcinski MA, Soong L. Source Morphological Sciences Program, Biomedical Scienc...http://www.siliconinvestor.com/readmsg.aspx?msgid=287573283/3/2013 3:26:46 PMrjk01go and get him for royalties, or at least a public admission for copy right infringement. Though he forgot the Christmas double dipping balboa island cruise.http://www.siliconinvestor.com/readmsg.aspx?msgid=287485112/26/2013 8:34:15 PMTerry D.Write it? I didn't even read it. Maybe it as a copy and past of the ones I've written over the years. *L*http://www.siliconinvestor.com/readmsg.aspx?msgid=287483572/26/2013 6:27:06 PMrjk01Hi Terry, did you write the article this morning? Loved the line about the millions of "well deserved" bonus's and 30 y of stellar achievements.http://www.siliconinvestor.com/readmsg.aspx?msgid=287479032/26/2013 2:44:09 PMrjk01what the indication to those assertions , does not make sense......but nothing those boys are involve in will surprise me. they have 20y of a prefect record to go on (on the "up to no good" scale)http://www.siliconinvestor.com/readmsg.aspx?msgid=287457492/25/2013 3:02:00 PMTerry D.If it was deliberate on our side it would be disastrous. Whichever side found to do this on purpose should end up in prison.http://www.siliconinvestor.com/readmsg.aspx?msgid=287441112/24/2013 5:46:42 PMRobert C. JonsonTerry, What do you think the market reaction will be if it is revealed that the coding errors in our 2nd line NSCLC trial were done deliberately? Best, Bobhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287439072/24/2013 3:11:35 PMrjk01imgn (T-DM1) is my biggest holding..........the approval was priced in, still hope to see double dig by year endhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287432812/24/2013 1:01:04 AMTerry D.I want Peregrine to succeed getting a drug to market as much if not more than most posters and investors and it's not because of the monetary gains. Those who continue to ignore failures and blame these failures on posters who do not post glowing reports with every post is beyond belief. If you want someone to blame, b...http://www.siliconinvestor.com/readmsg.aspx?msgid=287418462/22/2013 7:17:12 PMTerry D. FDA Approves Ado-Trastuzumab Emtansine for Metastatic Breast Cancer ROCKVILLE, Md -- February 22, 2013 -- The US Food and Drug Administration (FDA) has approved ado-trastuzumab emtansine (Kadcyla) for patients with human epidermal growth factor receptor 2 (HER2)-positive, metastatic breast cancer. The drug i...http://www.siliconinvestor.com/readmsg.aspx?msgid=287418292/22/2013 7:08:12 PMrjk01time to hype again, price it taking a dive........need to justify the coming bonus, some urgent need for PRhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287369172/20/2013 4:03:47 PMRobert C. Jonsonyou would think there is no way they have more tricks in their bag. Actually, I don't think they've begun to fight! (Apologies to J.P.J. :-)http://www.siliconinvestor.com/readmsg.aspx?msgid=287241922/13/2013 5:00:23 PMrjk01you would think there is no way they have more tricks in their bag...........but count on king to outdo himself again..........as well as print more money for well deserved raise and bonus.......... after all he got the price to go from 10 cents to 50 cents the last few months......not badhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287241492/13/2013 4:34:46 PMTerry D.I can't even play golf. I had shoulder surgery the 31st. If I had any brains I'd be playing this stock like everyone else. Unfortunately I'd feel it would be like cheating on a wife or girlfriend if I did because I got into Techniclone for personal reasons.http://www.siliconinvestor.com/readmsg.aspx?msgid=287241412/13/2013 4:31:02 PMRobert C. JonsonTerry, I marvel that you're still a PPHM investor. This latest news sure shows what a risky stock this is! At least I hope your golf game is still intact! :-) Bobhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287240482/13/2013 3:54:24 PMTerry D.http://www.siliconinvestor.com/readmsg.aspx?msgid=287239462/13/2013 3:20:38 PMTerry D.You'd think after 24 years I would have learned my lesson. Sell into the news and buy back at a substantially lower price. More dilution via ATM today? Bob: Email back and ask what events were reached. But today's tanked PPS I'd say you are one of the few comforted by Keenans's reply "I emailed Chris Keenan at IR...http://www.siliconinvestor.com/readmsg.aspx?msgid=287239432/13/2013 3:18:47 PMrjk01http://www.siliconinvestor.com/readmsg.aspx?msgid=287239152/13/2013 3:11:19 PM